Suppr超能文献

在冠状动脉介入治疗时代,谁能从轻度治疗性低温中获益最多?一项回顾性和倾向评分匹配研究。

Who benefits most from mild therapeutic hypothermia in coronary intervention era? A retrospective and propensity-matched study.

机构信息

Department of Cardiology, Hiroshima City Hospital, 7-33 Moto-machi, Naka-ku, Hiroshima 730-8518, Japan.

出版信息

Crit Care. 2010;14(4):R155. doi: 10.1186/cc9225. Epub 2010 Aug 16.

Abstract

INTRODUCTION

The aim of the present study was to investigate the impact of the time interval from collapse to return of spontaneous circulation (CPA-ROSC) in cardiac arrest patients and the types of patients who will benefit from therapeutic hypothermia.

METHODS

Four hundred witnessed adult comatose survivors of out-of-hospital cardiac arrest of cardiac etiology were enrolled in the study. The favorable neurological outcome was defined as category 1 or 2 on the five-point Pittsburgh cerebral performance scale at the time of hospital discharge. A matching process based on the propensity score was performed to equalize potential prognostic factors in the hypothermia and normothermia groups, and to formulate a balanced 1:1 matched cohort study.

RESULTS

The rate of favorable neurological outcome was higher (P < 0.05) in the hypothermia group (n = 110) than in the normothermia group in patients with CPA-ROSC of 15 to 20 minutes (64% vs. 17%), 20 to 25 minutes (70% vs. 8%), 25 to 30 minutes (50% vs. 7%), 35 to 40 minutes (27% vs. 0%) and 40 to 45 minutes (29% vs. 2%). A similar association was observed in a propensity-matched cohort, but the differences were not significant. There was no significant difference in the rate of favorable neurological outcome between the hypothermia-matched group and the normothermia-matched group. In the patients whose CPA-ROSC was greater than 15 minutes, however, the rate of favorable neurological outcome was higher in the hypothermia-matched group than in the normothermia-matched group (27% vs. 4%, P < 0.001). In multivariate analysis, the CPA-ROSC was an independent predictor of favorable neurological outcome (every 1 minute: odds ratio = 0.89, 95% confidence interval = 0.85 to 0.92, P < 0.001).

CONCLUSIONS

The CPA-ROSC is an independent predictor of neurological outcome. Therapeutic hypothermia is more beneficial in comatose survivors of cardiac arrest with CPA-ROSC greater than 15 minutes.

摘要

简介

本研究旨在探讨心脏骤停患者从心脏停搏到自主循环恢复(ROSC)的时间间隔(CPA-ROSC)的影响,以及哪些类型的患者将从治疗性低温中获益。

方法

本研究纳入了 400 名院外心脏骤停的成年昏迷幸存者,其病因均为心脏原因。出院时的医院神经功能预后良好定义为 Pittsburgh 脑功能表现量表的 5 分制的 1 或 2 分。基于倾向评分进行匹配过程,以在低温和常温组中均衡潜在的预后因素,并制定平衡的 1:1 匹配队列研究。

结果

在 CPA-ROSC 为 15-20 分钟(64%比 17%)、20-25 分钟(70%比 8%)、25-30 分钟(50%比 7%)、35-40 分钟(27%比 0%)和 40-45 分钟(29%比 2%)的患者中,低温组的神经功能预后良好率(n=110)高于常温组(P<0.05)。在倾向评分匹配的队列中也观察到了类似的关联,但差异无统计学意义。低温匹配组和常温匹配组的神经功能预后良好率无显著差异。然而,在 CPA-ROSC 大于 15 分钟的患者中,低温匹配组的神经功能预后良好率高于常温匹配组(27%比 4%,P<0.001)。在多变量分析中,CPA-ROSC 是神经功能预后良好的独立预测因素(每 1 分钟:比值比=0.89,95%置信区间=0.85 至 0.92,P<0.001)。

结论

CPA-ROSC 是神经功能预后的独立预测因素。对于 CPA-ROSC 大于 15 分钟的心脏骤停昏迷幸存者,治疗性低温更有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88f4/2945139/e898c867574d/cc9225-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验